<?xml version="1.0" encoding="UTF-8"?>
<ref id="cas13513-bib-0012">
 <label>12</label>
 <mixed-citation publication-type="journal" id="cas13513-cit-0012">
  <string-name>
   <surname>Ogura</surname>
   <given-names>M</given-names>
  </string-name>, 
  <string-name>
   <surname>Ishida</surname>
   <given-names>T</given-names>
  </string-name>, 
  <string-name>
   <surname>Hatake</surname>
   <given-names>K</given-names>
  </string-name>, et al. 
  <article-title>Multicenter phase II study of mogamulizumab (KW‐0761), a defucosylated anti‐cc chemokine receptor 4 antibody, in patients with relapsed peripheral T‐cell lymphoma and cutaneous T‐cell lymphoma</article-title>. 
  <source>J Clin Oncol</source>. 
  <year>2014</year>;
  <volume>32</volume>:
  <fpage>1157</fpage>‐
  <lpage>1163</lpage>.
  <pub-id pub-id-type="pmid">24616310</pub-id>
 </mixed-citation>
</ref>
